New Delhi, Sept. 12 -- Aligning with the Centre's 'Go Local' vision, the Technology Development Board (TDB), part of the Department of Science and Technology (DST), has granted support to Hyderabad-based Aodh Lifesciences Pvt. Ltd. for developing an indigenous nebulized antibiotic therapy targeting pneumonia and antimicrobial resistance (AMR).
The project pertains to development of novel drug formulation AONEUM-04, which promises to revolutionize the treatment of lower respiratory tract infections.
According to a TDB statement here, unlike traditional antibiotics administered orally or intravenously, AONEUM-04 is delivered directly to the lungs via nebulization, allowing for a higher concentration of the medicine at the infection site whi...